MEKINIST 0.5 mg, film-coated tablet 30 tablets
Active ingredients: Trametinib dimethyl sulfoxide, Trametinib
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- MEKINIST 0,5 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 30 comprimé(s)
- Marketing authorisation holder
- NOVARTIS EUROPHARM (IRLANDE)
- Reimbursement according to BDPM
- 100%
- Reimbursement conditions
- Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br>- Traitement de certains types de mélanomes très graves ou avec des métastases, en association au dabrafenib<br>- Cancer du poumon, après échec d'un premier traitement autre ; JOURNAL OFFICIEL ; 22/11/16
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 25 Nov 2016
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62348191CIP72794435CIP133400927944352Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TRAMÉTINIBcomprimé | 0,5 mg · un comprimé | FT |
| DIMETHYLSUFLOXYDE DE TRAMÉTINIBcomprimé | 0,563 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.